← Back to Search

Non-invasive Brain Stimulation

20 Hz rTMS for Schizophrenia (rTMS-FPCC Trial)

N/A
Waitlist Available
Led By Tom Hummer, PhD
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day
Awards & highlights

rTMS-FPCC Trial Summary

This trial will test the effects of a new treatment for psychosis on the brain.

rTMS-FPCC Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 day for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in BOLD Signal in Anterior Cingulate Cortex
Change in Cognitive Control Network Functional Connectivity

rTMS-FPCC Trial Design

2Treatment groups
Experimental Treatment
Group I: 20 Hz rTMS targeting the LDLPFC first, then 20 Hz rTMS targeting the LSPCExperimental Treatment1 Intervention
Group II: 20 Hz rTMS Targeting the LSPC first, then 20 Hz rTMS Targeting the LDLPFCExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
20 Hz rTMS
2020
N/A
~20

Find a Location

Who is running the clinical trial?

Indiana UniversityLead Sponsor
980 Previous Clinical Trials
983,287 Total Patients Enrolled
14 Trials studying Schizophrenia
1,003 Patients Enrolled for Schizophrenia
Tom Hummer, PhDPrincipal InvestigatorIndiana University
Michael M Francis, MDPrincipal InvestigatorIndiana University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research project currently have open enrolment?

"Affirmative. Information accessible on clinicaltrials.gov reveals that this research project, which was first launched on March 12th 2020, is actively looking for participants. Approximately 20 people are needed to be recruited from two medical sites."

Answered by AI

Does the maximum age limit for this research project extend beyond seventy-five years?

"This trial seeks adult patients in the 18 to 40 age range; for those under 18, there are 46 other trials available and 165 studies that cater to those over 65."

Answered by AI

Is enlistment in this scientific experiment open to the public?

"This research endeavour is seeking 20 individuals, aged 18-40 and diagnosed with schizophrenia. Study candidates must have had their illness for less than a decade, be able to commit to the trial's timeline, not have experienced recent flare ups necessitating specialised psychiatric care such as hospitalisation or emergency consultation in the last month, and been on stable antipsychotic medication over that period of time."

Answered by AI

What is the current size of this clinical trial's participant group?

"Yes, the details outlined on clinicaltrials.gov confirm that this experiment is actively searching for participants. The trial was first posted in March of 2020 and has been recently updated in December 2021. A total of 20 patients must be recruited from 2 medical sites."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Interactions of Fronto-Parietal High Frequency rTMS on Anterior Cingulate Cortex Activation in Schizophrenia
Tom Hummer 2020. "Interactions of Fronto-Parietal High Frequency rTMS on Anterior Cingulate Cortex Activation in Schizophrenia". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04309370.
~3 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top